Literature DB >> 27472452

Cognitive behaviour therapy for specific phobia of vomiting (Emetophobia): A pilot randomized controlled trial.

Lori Riddle-Walker1, David Veale2, Cynthia Chapman3, Frank Ogle4, Donna Rosko5, Sadia Najmi6, Lana M Walker7, Pete Maceachern8, Thomas Hicks5.   

Abstract

This is the first randomised controlled trial to evaluate a protocol for cognitive behaviour therapy (CBT) for a Specific Phobia of Vomiting (SPOV) compared with a wait list and to use assessment scales that are specific for a SPOV.
METHOD: 24 participants (23 women and 1 man) were randomly allocated to either 12 sessions of CBT or a wait list.
RESULTS: At the end of the treatment, CBT was significantly more efficacious than the wait list with a large effect size (Cohen's d=1.53) on the Specific Phobia of Vomiting Inventory between the two groups after 12 sessions. Six (50%) of the participants receiving CBT achieved clinically significant change compared to 2 (16%) participants in the wait list group. Eight (58.3%) participants receiving CBT achieved reliable improvement compared to 2 (16%) participants in the wait list group.
CONCLUSIONS: A SPOV is a condition treatable by CBT but further developments are required to increase efficacy.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive behaviour therapy; Emetophobia; Exposure; Randomised controlled trial; Specific phobia; Vomiting

Mesh:

Year:  2016        PMID: 27472452     DOI: 10.1016/j.janxdis.2016.07.005

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  2 in total

1.  Psychometric investigation of the specific phobia of vomiting inventory: A new factor model.

Authors:  Danielle J Maack; Chad Ebesutani; Todd A Smitherman
Journal:  Int J Methods Psychiatr Res       Date:  2017-07-25       Impact factor: 4.035

Review 2.  Recent developments in the intervention of specific phobia among adults: a rapid review.

Authors:  Christabel E W Thng; Nikki S J Lim-Ashworth; Brian Z Q Poh; Choon Guan Lim
Journal:  F1000Res       Date:  2020-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.